Annual ROE
114.53%
+48.20%+72.67%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual return on equity is 114.53%, with the most recent change of +48.20% (+72.67%) on December 31, 2023.
- During the last 3 years, CHRO annual ROE has risen by +96.07% (+520.42%).
- CHRO annual ROE is now at all-time high.
Performance
CHRO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
581.58%
+237.95%+69.25%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly return on equity is 581.58%, with the most recent change of +237.95% (+69.25%) on September 30, 2024.
- Over the past year, CHRO quarterly ROE has increased by +445.22% (+326.50%).
- CHRO quarterly ROE is now at all-time high.
Performance
CHRO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CHRO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.7% | +326.5% |
| 3 y3 years | +520.4% | +7844.1% |
| 5 y5 years | +520.4% | +7844.1% |
CHRO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +607.9% | at high | +1201.1% |
| 5 y | 5-year | at high | +607.9% | at high | +1201.1% |
| alltime | all time | at high | +607.9% | at high | +1201.1% |
Chromocell Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 581.58%(+69.2%) |
| Jun 2024 | - | 343.63%(+54.3%) |
| Mar 2024 | - | 222.74%(+63.3%) |
| Dec 2023 | 114.53% | 136.36%(+40.2%) |
| Sep 2023 | - | 97.27%(-284.2%) |
| Jun 2023 | - | -52.82%(+87.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -28.17%(+115.2%) |
| Dec 2022 | 66.33%(+310.0%) | -13.09%(+74.3%) |
| Sep 2022 | - | -7.51%(-132.3%) |
| Jun 2022 | - | 23.22%(+64.2%) |
| Mar 2022 | - | 14.14%(+147.6%) |
| Dec 2021 | 16.18%(-12.4%) | 5.71% |
| Dec 2020 | 18.46% | - |
FAQ
- What is Chromocell Therapeutics annual return on equity?
- What is the all time high annual ROE for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual ROE year-on-year change?
- What is Chromocell Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly ROE year-on-year change?
What is Chromocell Therapeutics annual return on equity?
The current annual ROE of CHRO is 114.53%
What is the all time high annual ROE for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual return on equity is 114.53%
What is Chromocell Therapeutics annual ROE year-on-year change?
Over the past year, CHRO annual return on equity has changed by +48.20% (+72.67%)
What is Chromocell Therapeutics quarterly return on equity?
The current quarterly ROE of CHRO is 581.58%
What is the all time high quarterly ROE for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly return on equity is 581.58%
What is Chromocell Therapeutics quarterly ROE year-on-year change?
Over the past year, CHRO quarterly return on equity has changed by +445.22% (+326.50%)